SCHEMBL27475747

SCHEMBL27475747

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)C(O)CS(=O)(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.69
▸ LMNA P02545 2/20 0.69
▸ NR3C1 P04150 8/20 0.69
▸ SMN1; SMN2 Q16637 3/20 0.69
▸ CYP2C19 P33261 2/20 0.69
▸ HSD17B10 Q99714 2/20 0.69
▸ PGR P06401 2/20 0.69
▸ SERPINA6 P08185 2/20 0.69
▸ CYP3A4 P08684 2/20 0.69
▸ NFKB1 P19838 2/20 0.69
▸ MAPT P10636 2/20 0.69
▸ SHBG P04278 1/20 0.69
▸ NR3C2 P08235 1/20 0.69
▸ KMT2A Q03164 1/20 0.69
▸ AR P10275 1/20 0.64
▸ CHRM1 P11229 1/20 0.64
▸ PMP22 Q01453 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ POLB P06746 1/20 0.57
▸ GAA P10253 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3108473 1.00 HIF1A (0.69) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL29064801 0.89 HIF1A (0.73) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL11814284 0.88 HIF1A (0.81) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL607956 0.88 HIF1A (0.72) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL16020569 0.86 HIF1A (0.78) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL603002 0.86 HIF1A (0.69) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL7614974 0.86 HIF1A (0.77) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL8071547 0.86 HIF1A (0.77) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL29064789 0.85 HIF1A (0.68) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL9437393 0.85 HIF1A (0.75) HIF1ALMNANR3C1SMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071537-B Use of glucocorticoid receptor modulators for potentiating checkpoint inhibitors 科赛普特治疗学股份有限公司 2024-07-05 — — CN disclosed
CN-117229344-A Preparation method of halcinonide 湖南中南制药有限责任公司 2023-12-15 — — CN disclosed
CN-107530339-B Glucocorticoid receptor antagonists in combination with glucocorticoids for the treatment of adrenal insufficiency 科赛普特治疗学股份有限公司 2021-03-16 — — CN disclosed
CN-109071537-A For reinforcing the application of the glucocorticoid receptor modulator of checkpoint inhibitor 科赛普特治疗学股份有限公司 2018-12-21 — — CN disclosed
CN-107530339-A Glucocorticoid receptor antagonists in combination with glucocorticoids for the treatment of adrenal insufficiency 科赛普特治疗学股份有限公司 2018-01-02 — — CN disclosed
CN-107530435-A Treatment of ACTH-secreting tumors using glucocorticoid receptor antagonists and somatostatin 科赛普特治疗学股份有限公司 2018-01-02 — — CN disclosed
CN-105007932-A Flowable formulations for tissue repair and regeneration TISSUE REPAIR COMPANY 2015-10-28 — — CN disclosed
CN-1130200-C Glucocorticoid receptor antagonists for treatment of dementia UNIV LELAND STANFORD JUNIOR (US) 2003-12-10 — — CN disclosed
CN-1292701-A Glucocorticoid receptor antagonists for the treatment of dementia UNIV LELAND STANFORD JUNIOR (US) 2001-04-25 — — CN disclosed
Send feedback